Regenerex Pharma (RGPX) FCF Margin (2014 - 2020)
Regenerex Pharma (RGPX) reported FCF Margin of 9239.78% for Q4 2020, down 1320202.0% year-over-year from N/an in Q1 2020, and up 5.26% quarter-over-quarter from 9752.5% in Q3 2020.
Regenerex Pharma (RGPX) FCF Margin (2014 - 2020) Analysis & Trends
Regenerex Pharma (RGPX) has 3 years of FCF Margin data on file, last reported at 9239.78% in Q4 2020.
- FCF Margin for Q4 2020 came in at 9239.78%, down 1320202.0% year-over-year; the trailing twelve-month figure through Dec 2020 was 41801.6% (changed N/A YoY), and the FY2020 annual result was 11394.9%, changed N/A from the prior year.
- FCF Margin rose to 9239.78% in Q4 2020 per RGPX's latest filing, from 9752.5% in the prior quarter.
- Over five years, FCF Margin peaked at 3962.24% in Q4 2019 and troughed at 54657.31% in Q1 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -9,239.78% |
| Sep 30, 2020 | -9,752.50% |
| Jun 30, 2020 | -11,850.65% |
| Mar 31, 2020 | -54,657.31% |
| Dec 31, 2019 | 3,962.24% |
| Aug 31, 2014 | -44.70% |